Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+44 1300 500008

Volume 16, Issue 3 (2024)

Research

Pages: 1 - 16

The HTLV-1 Latency-Maintenance Factor p30II Induces the Phosphorylation and Hypoxia-Independent Mitochondrial Targeting of TIGAR Analogous to Tyrosine Kinase Receptor-Signaling and Suppresses Oncogene-Induced Oxidative Toxicity

Robert Harrod*, Tetiana Bowley, Aditi Malu, Natalie M. Adams, Julia Savage, Melika Saberi, Mya VanderHagen, Reena Alame, Makenna Keating and Courtney Yates

DOI: 10.35248/1948-5964.24.16.313

Share this article

Opinion

Pages: 1 - 2

Continuous Effort Against Viral Infections: Achieving Optimal Health

Maxumer Gadhan

DOI: 10.35248/1948-5964.24.16.322

Share this article

Perspective

Pages: 1 - 1

The Potential of Antiviral Nanomedicine: A Gateway to Future Therapies

Obacco Nyasia*

DOI: 10.35248/1948-5964.24.16.323

Share this article

Opinion Article

Pages: 1 - 1

The Power and Potential of CRISPR-Cas Systems in Antiviral and Anti-Retroviral Therapies

Kelgay Janey*

DOI: 10.35248/1948-5964.24.16.324

Share this article

Perspective

Pages: 1 - 1

Targeting Viral Entry: New Frontiers in Antiviral Drug Development

Jmily Carter*

DOI: 10.35248/1948-5964.24.16.325

Share this article

Opinion

Pages: 1 - 1

Immunomodulatory Approaches for Enhanced Antiviral Defense

Farah Zhompson

DOI: 10.35248/1948-5964.24.16.326

Share this article

Perspective

Pages: 1 - 1

Using FDA-Approved Drugs for Antiviral and Anti-Retroviral Therapy: A Promising Strategy for Global Health

Makers Pater

DOI: 10.35248/1948-5964.24.16.327

Share this article

Perspective

Pages: 1 - 1

Next-Generation Antiviral Vaccines: Innovations and Progress

Micle Patel*

DOI: 10.35248/1948-5964.24.16.330

Share this article

Opinion Article

Pages: 1 - 1

CRISPR an Innovative Approaches to Treat Viral Dieases

Emily Parker*

DOI: 10.35248/1948-5964.24.16.328

Share this article

Perspective

Pages: 1 - 1

Host-Virus Interactions: Implications for Antiviral Drug Discovery

Haker Mader*

DOI: 10.35248/1948-5964.24.16.329

Share this article
Top